skip to content

Emmaus Life Sciences Issues Statement In Response to Announcement by AFH Holding & Advisory

October 10, 2012

TORRANCE, Calif., October 10, 2012 - Emmaus Life Sciences, Inc., a specialty pharmaceutical and regenerative medicine company, today issued the following statement in response to an announcement issued October 9, 2012, by AFH Holding & Advisory, LLC.

Emmaus Life Sciences has a pending lawsuit in California against AFH Holding & Advisory, which was filed in July 2012. The Company believes the claims filed by AFH Holding & Advisory in Delaware appear to be nothing more than a reaction to the California lawsuit. The company believes AFH’s claims are completely without merit and it will defend them vigorously.